Cargando…
Dosing down with biologic therapies: a systematic review and clinicians’ perspective
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850841/ https://www.ncbi.nlm.nih.gov/pubmed/29240954 http://dx.doi.org/10.1093/rheumatology/kex503 |
| _version_ | 1783306293869543424 |
|---|---|
| author | Edwards, Christopher J Fautrel, Bruno Schulze-Koops, Hendrik Huizinga, Tom W J Kruger, Klaus |
| author_facet | Edwards, Christopher J Fautrel, Bruno Schulze-Koops, Hendrik Huizinga, Tom W J Kruger, Klaus |
| author_sort | Edwards, Christopher J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5850841 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58508412018-03-23 Dosing down with biologic therapies: a systematic review and clinicians’ perspective Edwards, Christopher J Fautrel, Bruno Schulze-Koops, Hendrik Huizinga, Tom W J Kruger, Klaus Rheumatology (Oxford) Corrigenda Oxford University Press 2018-03 2017-12-12 /pmc/articles/PMC5850841/ /pubmed/29240954 http://dx.doi.org/10.1093/rheumatology/kex503 Text en © The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Corrigenda Edwards, Christopher J Fautrel, Bruno Schulze-Koops, Hendrik Huizinga, Tom W J Kruger, Klaus Dosing down with biologic therapies: a systematic review and clinicians’ perspective |
| title | Dosing down with biologic therapies: a systematic review and clinicians’ perspective |
| title_full | Dosing down with biologic therapies: a systematic review and clinicians’ perspective |
| title_fullStr | Dosing down with biologic therapies: a systematic review and clinicians’ perspective |
| title_full_unstemmed | Dosing down with biologic therapies: a systematic review and clinicians’ perspective |
| title_short | Dosing down with biologic therapies: a systematic review and clinicians’ perspective |
| title_sort | dosing down with biologic therapies: a systematic review and clinicians’ perspective |
| topic | Corrigenda |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850841/ https://www.ncbi.nlm.nih.gov/pubmed/29240954 http://dx.doi.org/10.1093/rheumatology/kex503 |
| work_keys_str_mv | AT edwardschristopherj dosingdownwithbiologictherapiesasystematicreviewandcliniciansperspective AT fautrelbruno dosingdownwithbiologictherapiesasystematicreviewandcliniciansperspective AT schulzekoopshendrik dosingdownwithbiologictherapiesasystematicreviewandcliniciansperspective AT huizingatomwj dosingdownwithbiologictherapiesasystematicreviewandcliniciansperspective AT krugerklaus dosingdownwithbiologictherapiesasystematicreviewandcliniciansperspective |